Systemic administration of a soluble betaglycan suppresses tumor growth, angiogenesis, and matrix metalloproteinase-9 expression in a human xenograft model of prostate cancer

Document Details

Document Type
Pub Defense Publication
Publication Date
Oct 05, 2004
Source ID
10.1002/pros.20166

Entities

People

  • Abhik Bandyopadhyay
  • Fernando López-casillas
  • I-tien Yeh
  • Long Wang
  • Luzhe Sun
  • Valentín Mendoza

Organizations

  • National Institutes of Health